Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona Psoriasis Registry
Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona Psoriasis Registry
复制标题
DOI:
10.1136/bmjopen-2018-027535
复制
发表时间:
2019-06-01
期刊:
影响因子:
2.9
通讯作者:
Lebwohl, Mark
中科院分区:
文献类型:
--
作者:
Strober, Bruce;Greenberg, Jeffrey D.;Lebwohl, Mark
Objectives This analysis examined the association between psoriasis severity, assessed by body surface area (BSA) and the Investigator's Global Assessment (IGA; previously used only in clinical trials), and patient-reported outcomes (PROs) in a real-world setting.Design Cross-sectional analysis within the Corrona Psoriasis Registry, an independent, prospective registry.Setting 70 dermatology practices in the USA.Participants 1529 adult patients with psoriasis being treated with biological or non-biological systemic psoriasis treatment by 31 May 2016.Primary and secondary outcome measures Psoriasis severity was assessed by percentage of affected BSA (mild (0%-5%), moderate (>5%-10%), severe (>10%-15%), very severe (>15%)) and IGA scores (clear/almost clear (0-1), mild (2), moderate (3), severe (4)). PROs (pain, itch, fatigue; Dermatology Life Quality Index [DLQI]; EuroQoL Visual Analogue Scale [EQ-VAS]; Work Productivity and Activity Impairment [WPAI]) were compared across BSA and IGA levels using analysis of variance and X-2 tests. The association between psoriasis severity and PROs was examined using multivariable regression models.Results The mean age was 50.6 years and 47% of patients were female. Consistently with more severe psoriasis, symptoms worsened, DLQI scores increased (p